Multimodality imaging is a comprehensive strategy to investigate left ventricular hypertrophy (LVH), providing morphologic, functional, and often clinical information to clinicians. Hypertrophic cardiomyopathy (HCM) is defined by an increased LV wall thickness not only explainable by abnormal loading conditions. In the context of HCM, multimodality imaging, by different imaging techniques, such as echocardiography, cardiac magnetic resonance, cardiac computer tomography, and cardiac nuclear imaging, provides essential information for diagnosis, sudden cardiac death stratification, and management. Furthermore, it is essential to uncover the specific cause of HCM, such as Fabry disease and cardiac amyloidosis, which can benefit of specific treatments. This review aims to elucidate the current role of multimodality imaging in adult patients with HCM.

Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes / Monda, Emanuele; Palmiero, Giuseppe; Lioncino, Michele; Rubino, Marta; Cirillo, Annapaola; Fusco, Adelaide; Caiazza, Martina; Verrillo, Federica; Diana, Gaetano; Mauriello, Alfredo; Iavarone, Michele; Losi, Maria Angela; De Rimini, Maria Luisa; Dellegrottaglie, Santo; D'Andrea, Antonello; Bossone, Eduardo; Pacileo, Giuseppe; Limongelli, Giuseppe. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 11:3(2022), p. 868. [10.3390/jcm11030868]

Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes

Diana, Gaetano;Losi, Maria Angela;Dellegrottaglie, Santo;Bossone, Eduardo;
2022

Abstract

Multimodality imaging is a comprehensive strategy to investigate left ventricular hypertrophy (LVH), providing morphologic, functional, and often clinical information to clinicians. Hypertrophic cardiomyopathy (HCM) is defined by an increased LV wall thickness not only explainable by abnormal loading conditions. In the context of HCM, multimodality imaging, by different imaging techniques, such as echocardiography, cardiac magnetic resonance, cardiac computer tomography, and cardiac nuclear imaging, provides essential information for diagnosis, sudden cardiac death stratification, and management. Furthermore, it is essential to uncover the specific cause of HCM, such as Fabry disease and cardiac amyloidosis, which can benefit of specific treatments. This review aims to elucidate the current role of multimodality imaging in adult patients with HCM.
2022
Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes / Monda, Emanuele; Palmiero, Giuseppe; Lioncino, Michele; Rubino, Marta; Cirillo, Annapaola; Fusco, Adelaide; Caiazza, Martina; Verrillo, Federica; Diana, Gaetano; Mauriello, Alfredo; Iavarone, Michele; Losi, Maria Angela; De Rimini, Maria Luisa; Dellegrottaglie, Santo; D'Andrea, Antonello; Bossone, Eduardo; Pacileo, Giuseppe; Limongelli, Giuseppe. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 11:3(2022), p. 868. [10.3390/jcm11030868]
File in questo prodotto:
File Dimensione Formato  
jcm-2022-losi.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Dominio pubblico
Dimensione 1.07 MB
Formato Adobe PDF
1.07 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/903621
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 20
social impact